Symphera Secures €2.4M to Transform Surgical Systems

Munich-based medtech company Symphera has raised €2.4 million in Seed financing to advance its innovative surgical systems. These systems are designed to automate tool-switching during laparoscopic procedures, making manual instrument changes a thing of the past.

• Innovative Solution: Symphera's system allows surgeons to switch between tools with the push of a button, similar to using a multipen. This enables surgeons to stay fully focused during operations.

• Benefits: Aims to streamline surgical workflows, reduce operating time, and improve post-operative patient outcomes.

• Market Demand: Symphera addresses the growing need for more efficient, minimally invasive surgeries, gaining support from leading experts and institutions in the field.

• Funding and Investors: The €2.4 million Seed round was led by High-Tech Gründerfonds (HTGF), with participation from Bayern Kapital, CARMA FUND, UnternehmerTUM Funding for Innovators, Stern Stewart Ventures, and international partners like IRCAD from Strasbourg.

• Next Steps: With the newly secured funding, Symphera plans to advance product development, conduct pre-clinical tests, and begin preparations for the certification process

Symphera's groundbreaking technology promises to transform laparoscopic surgery, making procedures faster, more efficient, and ultimately improving patient care worldwide. With strong backing from investors and medical experts, the company is poised to bring its innovation to operating rooms across the globe.